Publications

Marshall HS, Clarke M, Heath C, Quinn H, Richmond P, Crawford N, Elliott E, Toi C, Kynaston A, Booy R, Macartney K on behalf of the PAEDS investigators. Severe and complicated varicella and associated genotypes 10 years after introduction of a one dose varicella vaccine program. Journal of Infectious Diseases. 2019;219:391-99. doi: 10.1093/infdis/jiy518. [Full text]

Alqahtani AS, Fakeerh M, Bondagji D, Park S, Heywood AE, Wiley KE, Booy R, Rashid H. Hand hygiene compliance and effectiveness against respiratory infections among Hajj pilgrims: a systematic review. Infectious Disorders – Drug Targets. 2020;20(3):273-283. doi: 10.2174/1871526518666181001145041. [Abstract]

Qian J, Heywood AE, Karki S, Banks E, Macartney K, Chantrill L, Liu B. Risk of herpes zoster prior to and following cancer diagnosis and treatment: a population-based prospective cohort study. Journal of Infectious Diseases 2019;220:3-11. doi: 10.1093/infdis/jiy625. [Full text ]

Sellens E, Bosward KL, Willis S, Heller J, Cobbold R, Comeau JL, Norris JM, Dhand NK, Wood N. Frequency of adverse events following Q fever immunisation in young adults. Vaccines. 2018;6:83. doi: 10.3390/vaccines6040083. [Full text]

Dey A, Wang H, Quinn H, Cook J, Macartney K. Surveillance of adverse events following immunisation in Australia annual report, 2016. Communicable Diseases Intelligence 2018;42:S2209-6051(18)00011-8. doi: 10.33321/cdi.2018.42.9. [Full Text]

Badahdah AL, Tashani M, Khatami A, Booy R, Rashid H. Interaction of meningococcal conjugate vaccines with other conjugate or diphtheria-tetanus containing vaccines [letter]. Journal of Travel Medicine. 2018;25. https://doi.org/10.1093/jtm/tay112. [Full text]

Alqahtani AS, Heywood AE, Rashid H. Preparing Australian pilgrims for the Hajj 2018 [letter]. Journal of Travel Medicine. 2018;25. doi: 10.1093/jtm/tay068. [Abstract]

MacIntyre CR, Kpozehouen E, Kunasekaran M, Harriman K, Conaty S, Rosewell A, Druce J, Martin N, Heywood AE, Gidding HF, Wood J, Nicholl S. Measles control in Australia - threats, opportunities and future needs. Vaccine. 2018;36:4393-8. [Full text]

Patel C, Brotherton J, Pillsbury A, Jayasinghe S, Donovan B, Macartney K, Marshall H. The impact of ten years of HPV vaccination in Australia: what additional disease burden will a 9-valent vaccine prevent?. Eurosurveillance. October 2018;23. [Full text]

Bedford H, Attwell K, Danchin M, Marshall M, Corben P, Leask J. Vaccine hesitancy, refusal and access barriers: the need for clarity in terminology. Vaccine 2018;36:6556-8. [Full text]